- Home
- APLS vs CRGY Comparison
APLS vs CRGY Comparison
Compare APLS & CRGY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | APLS | CRGY |
|---|---|---|
| Founded | 2009 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7B | 2.3B |
| IPO Year | 2017 | N/A |
Fundamental Metrics
Financial Performance| Metric | APLS | CRGY |
|---|---|---|
| Price | $25.03 | $9.45 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 19 | 10 |
| Target Price | ★ $33.11 | $14.22 |
| AVG Volume (30 Days) | 2.2M | ★ 4.8M |
| Earning Date | 10-30-2025 | 11-03-2025 |
| Dividend Yield | N/A | ★ 5.11% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.36 | 0.10 |
| Revenue | $1,016,397,000.00 | ★ $3,590,024,000.00 |
| Revenue This Year | $29.00 | $29.14 |
| Revenue Next Year | N/A | $30.46 |
| P/E Ratio | ★ $70.45 | $90.51 |
| Revenue Growth | ★ 42.11 | 32.31 |
| 52 Week Low | $16.10 | $6.83 |
| 52 Week High | $35.71 | $16.94 |
Technical Indicators
Market Signals| Indicator | APLS | CRGY |
|---|---|---|
| Relative Strength Index (RSI) | 67.89 | 52.89 |
| Support Level | $23.54 | $9.35 |
| Resistance Level | $25.52 | $10.23 |
| Average True Range (ATR) | 0.92 | 0.32 |
| MACD | 0.61 | -0.01 |
| Stochastic Oscillator | 92.36 | 49.84 |
Price Performance
Historical ComparisonAbout APLS Apellis Pharmaceuticals Inc.
Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.
About CRGY Crescent Energy Company
Crescent Energy Co is an independent energy company with a portfolio of assets in key basins across the lower 48 states. The company maintains a diverse portfolio of assets in key basins across the United States, including the Eagle Ford, Rockies, Barnett, Permian, and Mid-Con. It seeks to deliver attractive risk-adjusted investment returns and predictable cash flows across cycles with a focus on operated oil and gas assets complemented by non-operated assets, mineral and royalty interests, and midstream infrastructure.